Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15041731rdf:typepubmed:Citationlld:pubmed
pubmed-article:15041731lifeskim:mentionsumls-concept:C1140680lld:lifeskim
pubmed-article:15041731lifeskim:mentionsumls-concept:C1706586lld:lifeskim
pubmed-article:15041731lifeskim:mentionsumls-concept:C0037083lld:lifeskim
pubmed-article:15041731lifeskim:mentionsumls-concept:C0079925lld:lifeskim
pubmed-article:15041731lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:15041731lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:15041731lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:15041731lifeskim:mentionsumls-concept:C0018270lld:lifeskim
pubmed-article:15041731lifeskim:mentionsumls-concept:C0812215lld:lifeskim
pubmed-article:15041731lifeskim:mentionsumls-concept:C2746015lld:lifeskim
pubmed-article:15041731lifeskim:mentionsumls-concept:C1515670lld:lifeskim
pubmed-article:15041731lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:15041731lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:15041731lifeskim:mentionsumls-concept:C1710082lld:lifeskim
pubmed-article:15041731lifeskim:mentionsumls-concept:C0599894lld:lifeskim
pubmed-article:15041731pubmed:issue6lld:pubmed
pubmed-article:15041731pubmed:dateCreated2004-3-25lld:pubmed
pubmed-article:15041731pubmed:abstractTextWe sought to identify determinants of growth response to the Raf-1-targeted antisense oligonucleotide (ASO; ISIS 5132) using a large panel of ovarian cancer cell lines.lld:pubmed
pubmed-article:15041731pubmed:languageenglld:pubmed
pubmed-article:15041731pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15041731pubmed:citationSubsetIMlld:pubmed
pubmed-article:15041731pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15041731pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15041731pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15041731pubmed:statusMEDLINElld:pubmed
pubmed-article:15041731pubmed:monthMarlld:pubmed
pubmed-article:15041731pubmed:issn1078-0432lld:pubmed
pubmed-article:15041731pubmed:authorpubmed-author:SmythJohn FJFlld:pubmed
pubmed-article:15041731pubmed:authorpubmed-author:MoniaBrettBlld:pubmed
pubmed-article:15041731pubmed:authorpubmed-author:LangdonSimon...lld:pubmed
pubmed-article:15041731pubmed:authorpubmed-author:MullenPeterPlld:pubmed
pubmed-article:15041731pubmed:authorpubmed-author:McPhillipsFio...lld:pubmed
pubmed-article:15041731pubmed:authorpubmed-author:MacLeodKennet...lld:pubmed
pubmed-article:15041731pubmed:issnTypePrintlld:pubmed
pubmed-article:15041731pubmed:day15lld:pubmed
pubmed-article:15041731pubmed:volume10lld:pubmed
pubmed-article:15041731pubmed:ownerNLMlld:pubmed
pubmed-article:15041731pubmed:authorsCompleteYlld:pubmed
pubmed-article:15041731pubmed:pagination2100-8lld:pubmed
pubmed-article:15041731pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:15041731pubmed:meshHeadingpubmed-meshheading:15041731...lld:pubmed
pubmed-article:15041731pubmed:meshHeadingpubmed-meshheading:15041731...lld:pubmed
pubmed-article:15041731pubmed:meshHeadingpubmed-meshheading:15041731...lld:pubmed
pubmed-article:15041731pubmed:meshHeadingpubmed-meshheading:15041731...lld:pubmed
pubmed-article:15041731pubmed:meshHeadingpubmed-meshheading:15041731...lld:pubmed
pubmed-article:15041731pubmed:meshHeadingpubmed-meshheading:15041731...lld:pubmed
pubmed-article:15041731pubmed:meshHeadingpubmed-meshheading:15041731...lld:pubmed
pubmed-article:15041731pubmed:meshHeadingpubmed-meshheading:15041731...lld:pubmed
pubmed-article:15041731pubmed:meshHeadingpubmed-meshheading:15041731...lld:pubmed
pubmed-article:15041731pubmed:meshHeadingpubmed-meshheading:15041731...lld:pubmed
pubmed-article:15041731pubmed:meshHeadingpubmed-meshheading:15041731...lld:pubmed
pubmed-article:15041731pubmed:meshHeadingpubmed-meshheading:15041731...lld:pubmed
pubmed-article:15041731pubmed:meshHeadingpubmed-meshheading:15041731...lld:pubmed
pubmed-article:15041731pubmed:year2004lld:pubmed
pubmed-article:15041731pubmed:articleTitleAntisense oligonucleotide targeting of Raf-1: importance of raf-1 mRNA expression levels and raf-1-dependent signaling in determining growth response in ovarian cancer.lld:pubmed
pubmed-article:15041731pubmed:affiliationCancer Research UK, Edinburgh Oncology Unit, Western General Hospital, Edinburgh, United Kingdom.lld:pubmed
pubmed-article:15041731pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:5894entrezgene:pubmedpubmed-article:15041731lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15041731lld:entrezgene
lhgdn:association:23428lhgdn:found_inpubmed-article:15041731lld:lhgdn